Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state.

Rounbehler, Robert J; Fallahi, Mohammad; Yang, Chunying; Steeves, Meredith A; Li, Weimin; Doherty, Joanne R; Schaub, Franz X; Sanduja, Sandhya; Dixon, Dan A; Blackshear, Perry J; Cleveland, John L

Rounbehler, Robert J; Fallahi, Mohammad; Yang, Chunying; Steeves, Meredith A; Li, Weimin; Doherty, Joanne R; Schaub, Franz X; Sanduja, Sandhya; Dixon, Dan A; Blackshear, Perry J; Cleveland, John L.

Affiliation

Rounbehler RJ; Department of Cancer Biology, The Scripps Research Institute, Scripps Florida, Jupiter, FL 33458, USA.

Cell ; 150(3): 563-74, 2012 Aug 03.

Article in En | MEDLINE | ID: mdl-22863009

Subject(s)

Genes, Tumor Suppressor; Lymphoma, B-Cell/metabolism; Proto-Oncogene Proteins c-myc/metabolism; Tristetraprolin/metabolism; Adaptor Proteins, Signal Transducing/genetics; Animals; B-Lymphocytes/metabolism; Cell Line, Tumor; Cell Transformation, Neoplastic; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; RNA Stability; RNA, Messenger/chemistry

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genes, Tumor Suppressor / Lymphoma, B-Cell / Proto-Oncogene Proteins c-myc / Tristetraprolin Limits: Animals / Humans Language: En Journal: Cell Year: 2012 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google